Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Income Taxes The Company estimates an annual effective tax rate of 0% for the year ending December 31, 2024 as the Company incurred losses for the six months ended June 30, 2024 and expects to continue to incur losses through the remainder of fiscal year ending December 31, 2024, resulting in an estimated net loss for both financial statement and tax purposes for the year ending December 31, 2024
Other neurological symptoms such as peripheral neuropathy, paresthesias, or allodynia have not been consistently reported as adverse effects attributable to semaglutide in controlled trials
Long-term weight maintenance appears more achievable with semaglutide than with diet alone, as the appetite-suppressing effect persists with continued use
Prioritise Sleep Aim for 79 hours of quality sleep per night
US$ 22.75
US$ 23.63
US$ 29.10
US$ 20.84
